Global Latex Medical Disposables Market: Snapshot
Latex medical disposables such as latex gloves are used during surgeries and check-ups. The demand for latex medical disposables is therefore quite high among doctors, surgeons, and dentists across the globe. Primarily, there are two types of latex gloves available in the market. These are powdered and non-powdered latex gloves. The non-powdered gloves might witness relatively more demand when compared with powdered gloves, as powdered gloves were found to be hindering the healing process of patients.
The market might encounter obstacles owing to the prevalence of latex allergies that induce several healthcare professionals to use non-latex products instead. Moreover, with the intensifying competition, the market players might have to bring down the prices of their products. As a result, sluggish growth in revenue might restrict the growth of the global market for latex medical disposables. However, the impact of these restraints will be negated by the emergence of novel technologies.
This 163 page report gives readers a comprehensive overview of the latex medical disposables market. Browse through 24 data tables and 53 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/latex-medical-disposables-market.html
The global market for latex medical disposables was pegged at US$4.1bn in 2015, and is expected to rise up to achieve US$6.4bn by the end of 2024, expanding at a CAGR of 4.9%.
Rising Demand from Countries in Asia Pacific to Accelerate Growth
Based on geography, the global latex medical disposables market has been segmented into Europe, Asia pacific, Latin America, the Middle East and Africa, and North America. The global latex medical disposables market is presently dominated by North America, which accounted for a 33% share of the global market during 2016, with Europe close-by at its heels. The increasing concerns about safety, growing awareness about health and the spread of contagious diseases, and increasing measures for preventing the spread of these diseases are some of the major factors driving the the market in Europe and North America.
Asia Pacific is also slated for substantial growth during the forecast period, expanding at a promising CAGR of 5.8% between 2016 and 2024. The countries in Asia Pacific such as India, Japan, Singapore, China, Australia, and Thailand are likely to represent a significant portion of the global market for latex medical disposables over the coming years. The growth of these regions can be attributed to the growing awareness about the safety of patients and healthcare professionals, rising per capita incomes of people, increasing healthcare expenditures of governments, and flourishing medical and pharmaceutical sectors in these regions.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving latex medical disposables market during 2016 – 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16109
Latex Gloves Emerge as Dominant Product Segment
By product, the global market for latex medical disposables has been segmented into latex, foley catheters, latex gloves, urine bags, latex probe covers, and others. Hospitals, clinics, ambulatory surgical centers, diagnostic centers, and others are the key segments by end user. Of these, latex gloves have been witnessing increasing demand over the past few years. As a result, these products have been dominating the global market. In terms of revenue, this product segment accounted for nearly 60.4% of the global market for latex medical disposables during 2015. Latex gloves might continue to hold the foremost position as these gloves are an easy and effective way of protecting the hands of patients and healthcare providers from the risk of infection.
By end user, the hospitals segment dominated the global market for latex medical disposables in terms of revenue during 2015. The increasing number of surgical procedures and check-ups in hospitals, coupled with establishment of new clinics and hospitals is responsible for the dominance of this segment. This segment is slated to contribute 28.7% to the global market for latex medical disposables by the end of 2024. The diagnostic centers segment might hold the second-most position over the forecast period.
Some of the major companies operating in the global market for latex medical disposables are Hartalega Holdings Bhd., Supermax Corporation Berhad, B. Braun Melsungen, C.R. Bard, Ansell, Top Glove Corporation, Dynarex Corporation, and Medtronic plc.
Global Mice Model Market: Snapshot
Biomedical research has taken a front seat in the healthcare and pharmaceutical industries, to a point where a nation’s research and development landscape can be gauged by its level of investment in biomedical research. The past decade has consequently witnessed a staggering rise in biomedical research in most countries, both developed and developing. A significant part of this research investment typically goes into animal models, more specifically, mice models. This forms the primary driver for the global mice models market.
Another factor promoting the increased use of mice models is the recent number of improvements that have been made in mice models. These improvements have not only enhanced their utility in current applications, but also increased the overall scope of applications for mice models. Biomedical research can use mice models for increasingly complex diseases, such as the use of mutated mice models for studying the ALS disease, or the use of advanced mice models to understand lung injury repair.
This 155 page report gives readers a comprehensive overview of the mice model market. Browse through 20 data tables and 79 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/mice-model-market.html
The factors above and similar ones that promote the use of mice models are responsible for imparting a positive growth rate to the global mice models market, which is expected to be valued at US$1.79 bn by the end of 2023.
Demand for Mice Models in North America Remains High
44.9% of the global market for mice models is expected to be held by North America in 2023, in terms of revenue. Europe at the same time is expected to emerge as the second-leading market for mice models, followed closely by Asia Pacific. North America and Europe have an established pharmaceutical industry and an advanced biosciences research field. Both regions are still showing a high demand for mice models that are meant to be used in advanced drug discovery processes and other medical research.
However, their overall share in the market value has dropped since 2014, owing to the significantly high demand for mice models in Asia Pacific. This region is showing an especially high demand for knockout and transgenic mice models. Close to half of the global mice models business in the world for these types is taken up by the Asia Pacific countries of China, India, Malaysia, and Singapore.
Inbred Mice Models Continue to Show High Demand, Demand for Hybrid Models on the Rise
Request a sample of this report to know what opportunities will emerge in the rapidly evolving mice model market during 2015 – 2023: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2085
Based on model types, the global market for mice models is expected to progress at a CAGR of 6.4% from 2015 to 2023, ending at US$1.79 bn by the end of 2023. Among the various mice model types, inbred mice models have consistently been the popular ones, owing to the ease with which scientists can reproduce the data and the overall cost effective system of obtaining inbred mice models. Additionally, the size of samples in inbred mice models can be considerably smaller than their outbred counterparts.
However, the demand for congenic or hybrid mice models is expected to rise significantly over the coming years owing to a high preference for them in the expanding cardiovascular research. Transgenic mice models are the second most popular models in the world. They possess a high volume of research capability in the fields of angiogenesis, breast cancer, and Alzheimer’s disease.
The key providers of mice models from a global standpoint include Charles River Laboratories, The Jackson Laboratory, Harlan Laboratories, and Taconic Biosciences.
Global Personal Mobility Devices Market: Key Trends
The rising geriatric population around the world has emerged as a key driver of the global personal mobility devices market. Transparency Market Research (TMR) projects demand for these devices to steadily increase in Asia Pacific, as the population of aged people increases in India and China. Apart from the geriatric population, caregiving services are also essential for people suffering from disability. A rise in the number of people living with a disability, either temporary or permanent, will fuel demand for personal mobility devices.
Despite witnessing positive growth worldwide, the high cost of these mobility devices will limit their market’s expansion to an extent. The low acceptance of digitized devices will also negatively impact the market’s trajectory. Nevertheless, grants from international organizations and favorable policies will boost sales of personal mobility devices in the coming years.
As per TMR, the global personal mobility devices market stood at US$6.65 bn in 2014. Rising at a CAGR of 7.30% between 2015 and 2023, the market is expected to reach US$12.7 bn by the end of 2023.
This 239 page report gives readers a comprehensive overview of the Personal Mobility Devices Market. Browse through 61 data tables and 97 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/personal-mobility-devices-market.html
Higher Purchasing Power of Consumers Puts North America in Dominant Position
North America currently leads the global personal mobility devices market. By revenue, the region held over 41.4% of the overall market in 2014, followed by Europe. Spurred by the rising geriatric population, coupled with the rising number of people with disability, the sales of personal mobility devices is expected to rise considerably in this region. North America has also proven lucrative for producers of technologically advanced devices. The region thus exhibits high demand digitized mobility devices. Furthermore, the increasing willingness among consumers to spend on advanced medical devices will provide improved sales opportunities to personal mobility devices manufacturers in North America.
Asia Pacific emerged as the third-largest market for personal mobility devices in 2014. However, TMR forecasts the regional market to rise at the highest CAGR during the forecast period. The increasing awareness about advanced medical devices, and their rising affordability, will boost demand for personal mobility devices in Asia Pacific. Furthermore, the increasing geriatric population reported in India and China, will augur well for the personal mobility devices market in Asia Pacific.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving Personal Mobility Devices Market during 2015 – 2023: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6715
Advent of Electric Wheelchairs Fuels Growth of Medical Mobility Aids and Ambulatory Devices Segment
The global personal mobility devices market can be bifurcated into medical mobility aids and ambulatory devices and medical furniture and bathroom safety products. Of these, the medical mobility aids and ambulatory devices segment dominated the market in 2014. The segment is expected to report the fastest CAGR of 8.5% during from 2015 to 2023. In this segment, wheelchairs emerged as the dominant sub-category in 2014. The increasing incidence of disability related to age, disease, or any physical injury fuels demand for wheelchairs considerably. Furthermore, the demand for electric wheelchairs is expected to rise in the forthcoming years as they provide better outdoor performance and are easy to drive.
Besides this, the medical furniture and bathroom safety products segment is expected to witness rising demand for medical beds in the near future. Overall, the segment is expected to report steady growth through the forecast period.
Some of the leading players operating in the global personal mobility devices market are Amigo Mobility International, Inc., Argo Medical, ArjoHuntleigh, Drive Medical, Graham-Field Health Products Incorporated, and Hill-Rom Holdings, Inc.
The global Kaposi sarcoma (KS) market is extremely consolidated with the top two players accounting for a combined share of almost 50% in 2015, finds Transparency Market Research (TMR). These companies are Johnson & Johnson and Merck & Co. Inc. Currently, the share of regional vendors, such as Sun Pharmaceutical Industries Limited, is noticeably low; however, in the coming years, their regional shares are anticipated to augment considerably, notes TMR. Owing to the large-scale patent expiry of numerous blockbuster drugs, particularly in the U.S., the market will expectedly witness several new entrants in the coming years. A significant number of these companies will be focusing on developing generics, unlocking a wealth of opportunities for leading drug makers.
Key strategies adopted by companies include partnerships and acquisitions; several market players are collaborating with prominent companies for developing new products with enhanced efficacy. The global Kaposi sarcoma market is anticipated to expand at a modest CAGR of 2.2% from 2016 to 2024. The market stood at US$118.5 mn in 2015 and is expected to reach US$143.2 mn by 2024.
This 131 page report gives readers a comprehensive overview of the Kaposi sarcoma market. Browse through 23 data tables and 35 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/kaposis-sarcoma-market.html
Chemotherapy Gaining Ground as Safe Treatment for Containing Kaposi Sarcoma
Geographically, the major regional markets for Kaposi sarcoma are Europe, North America, Asia Pacific, the Middle East & Africa (MEA), and Latin America. Of these, the Middle East and Africa market is projected to exhibit the most promising growth. The substantial demand for Kaposi sarcoma therapies is driven by its high prevalence and the increasing incidence of AIDS-induced Kaposi sarcoma in many parts of Eastern Africa.
Based on treatment method, the Kaposi sarcoma market is segmented into antiretroviral therapy, immunotherapy, and chemotherapy. Of these, the chemotherapy segment is expected to rise at a strong CAGR over the forecast period. The growing popularity of the treatment protocol is driven by its increased efficacy to contain cancer that has spread to multiple areas of the patient’s body. The treatment is also found to be effective in improving the quality of life in patients with classic or endemic Kaposi sarcoma.
Increasing Incidence Epidemic Kaposi Sarcoma to Boost Uptake of Antiretroviral Therapies
Since Kaposi sarcoma is one of the most common AIDS-defining malignancies, the increasing number of people who are HIV-positive has increased the incidence of AIDS-associated Kaposi sarcoma. The increasing efficiency of highly active antiretroviral therapy (HAART) in the treatment of epidemic or AIDS-related KS has boosted the growth of the market. The popularity of antiretroviral therapy (ART) as the key treatment modality to improve overall health and survival rate among AIDS-related KS is expected to fuel the market.
The increasing rate of organ transplant procedures has increased the vulnerability of patients to Kaposi sarcoma cancer. This is another crucial factor driving the Kaposi sarcoma market in various regions. The rising incidence of Kaposi sarcoma associated herpesvirus (KSHV) infection among patients who have undergone organ transplants is expected to spur the demand for KS treatments.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving Kaposi sarcoma market during 2016 – 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3354
However, the high cost of patented cancer drugs restrains patients especially in low- and middle-income countries to avail treatments, thereby hindering the growth of the market to an extent. On the other hand, the expected arrival of several generics and the soaring preference for chemo drugs among immunocompetent patients are expected to fuel the market over the forecast period. In addition, advancement in specific biomarkers in diagnosing KS is expected to open up lucrative market in the coming years.
The study presented here is based on a report by Transparency Market Research (TMR) titled “Kaposi Sarcoma Market (Treatment – Chemotherapy (Liposomal Anthracyclines and Alkaloids), Immunotherapy, and HAART); Distribution Channel – Hospitals, Cancer Research Institutes, Multispecialty Clinics, and Ambulatory Surgical Centers) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024.”
Transparency Market Research has published a new report on the Canada home healthcare market. According to the report, the Canada home healthcare market is expected to expand at an 8.90% CAGR from 2014 to 2020. The report, titled ‘Canada Home Healthcare Market – Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020,’ states that the market stood at US$10.45 bn in 2013 and is expected to reach US$18.94 bn by 2020 owing to the rising incidences of lifestyle and chronic diseases and the technical advantages in home healthcare services.
The Canada home healthcare market comprises a wide range of home healthcare services and devices to support people with chronic diseases. The prevalence and risk of chronic diseases are continually rising in Canada. This has led to the increasing acceptance of home healthcare services as hospital stays can be both expensive and inconvenient. The changing demographics in Canada are further expected to propel the Canada home healthcare market in the years to come. As per recent statistics, in Canada, there were around 5 million people aged over 60 years in 2011 and the number is predicted to reach 10.4 million in the next 25 years. Chronic diseases are more likely to be detected in elderly people. As the pool of aging people is expected to increase in Canada, the number of people affected by chronic diseases is expected to increase, thus benefiting the Canada home healthcare market.
This 113 page report gives readers a comprehensive overview of the Canada home healthcare market. Browse through 10 data tables and 42 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/canada-home-healthcare-market.html
The Canada home healthcare market is segmented on the basis of region, service, and device type. By device type, the Canada home healthcare market is classified into diagnostics and monitoring devices, home mobility assist devices, home healthcare devices, and medical supplies. In 2013, the diagnostics and monitoring devices segment held a share of 30% in the Canada home healthcare market. The Canada government is constantly taking efforts to spread awareness among people about various chronic diseases and illnesses such as hypertension, sleep apnea, and diabetes. Over the past few years, people have thus become aware of the benefits of home healthcare devices for the management of chronic diseases.
Factors such as challenging regulatory restrictions and the lack of training to operate home healthcare devices are expected to restrict the growth of the Canada home healthcare market in the years to come. However, the constantly rising disposable income, the rising pool of patients with chronic diseases, the development of home healthcare technologies, and the untapped market are some of the factors expected to propel the Canada home healthcare market in the years to come.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving Canada home healthcare market during 2014 – 2020: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4898
By service, the Canada home healthcare market is classified into telehealth and telemedicine, rehabilitation, infusion therapy, unskilled home healthcare, and respiratory therapy services. In 2013, the Canada home healthcare market was dominated by the unskilled home healthcare services owing to the rising geriatric population and the rising uptake of nonprofessional home healthcare services. The telehealth and telemedicine segment is expected to expand at an 11.0% CAGR from 2014 to 2020.
Based on region, the Canada home healthcare market is divided into Quebec, Ontario, Alberta, and Rest of Canada. In 2013, the Canada home healthcare market was dominated by Ontario owing to favorable government policies towards various home healthcare services. Johnson & Johnson, 3M Healthcare, We Care Health Services, Home Care Ontario, Omron Healthcare, GM Healthcare, and The Canadian Home Care Association are some of the key companies operating in the Canada home healthcare market.